Adare Pharma Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Adare Pharma Solutions's estimated annual revenue is currently $118M per year.
- Adare Pharma Solutions's estimated revenue per employee is $201,000
Employee Data
- Adare Pharma Solutions has 587 Employees.
Adare Pharma Solutions's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Marketing Manager | Reveal Email/Phone |
2 | Business Development | Inside Sales Manager | Reveal Email/Phone |
Adare Pharma Solutions Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Adare Pharma Solutions?
Adare Pharma Solutions is a global technology driven CDMO providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare's specialized technology platforms provide taste masking, ODTs, and customized drug release solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 40 products sold by customers in more than 100 countries globally.
keywords:N/A
N/A
Total Funding
587
Number of Employees
$118M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adare Pharma Solutions News
2022-03-22 - Outsourced Clinical Trials & Formulation Market is estimated ...
In recent years, pharmaceutical companies have been concentrating ... For example, on December 1, 2021, Adare Pharma Solutions acquired...
Other Companies in Lawrenceville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $179.9M | 634 | 5% | N/A |
#2 | $121.4M | 670 | N/A | N/A |
#3 | $200M | 816 | -2% | $315M |
#4 | $452.8M | 1540 | 7% | N/A |
#5 | $476.5M | 1891 | N/A | N/A |